Swedish Orphan Biovitrum AB (publ) BIOVF
$48.16 $0.17 (0.35%) 1D
Last Updated: Aug 20, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
BIOVF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Swedish Orphan Biovitrum AB (publ) is classified as halal.
HALAL
Report Source: undefined Quarter Report
Swedish Orphan Biovitrum AB (publ). Stock Analysis BIOVF
United States Health Care Large Cap Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceuticals. The company is headquartered in Stockholm, Stockholm and currently employs 1,969 full-time employees. The company went IPO on 2006-09-15. The firm develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company’s product portfolio is divided into three business segments: the Core Products segment offers pharmaceuticals within Inflammation area, and Genetics and metabolic therapeutic area; the Partner Products segment offers about 40 pharmaceuticals within hematology, oncology and emergency medicines, and the ReFacto Manufacturing segment. The firm has subsidiaries in Sweden, Denmark, Finland, Norway, United Kingdom and France, among others.
Swedish Orphan Biovitrum AB (publ) (BIOVF) Chart
Financial Metrics & Statements of Swedish Orphan Biovitrum AB (publ) (BIOVF)
FAQ's for Swedish Orphan Biovitrum AB (publ) (BIOVF)
- As of August 2026, Swedish Orphan Biovitrum AB (publ) BIOVF is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Swedish Orphan Biovitrum AB (publ) using these criteria to determine its compliance status.
- Muslim investors may consider investing in Swedish Orphan Biovitrum AB (publ) if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Swedish Orphan Biovitrum AB (publ) by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Swedish Orphan Biovitrum AB (publ) may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Swedish Orphan Biovitrum AB (publ) on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Swedish Orphan Biovitrum AB (publ) (BIOVF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
